Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1311-1320 of 2905 for cancer

Edit search filters
  1. A Study To Analyze The Safety And Effectiveness Of The NanoKnife® System In Unresectable Stage 3 Pancreatic Adenocarcinom Patients

    Jacksonville, FL, Rochester, MN

  2. Study Of Oraxol And Pembrolizumab In Subjects With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Bemarituzumab Or Placebo Plus Chemotherapy In Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Prostate Imaging Using MRI +/- Contrast Enhancement

    Rochester, MN

  5. IL-2 Plus FOLFOX And Nivolumab For Treatment Of Peritoneal Metastases

    Rochester, MN

  6. Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy In Early-Stage Resectable NSCLC (VIGOR)

    Rochester, MN

  7. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 In Combination With Soc, Versus SoC Alone, In Adult Male Patients With MHSPC

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Focal Prostate Ablation Utilizing TULSA Profound System

    Rochester, MN

  9. A Study Of GSK5458514 Administered Alone Or In Combination With Other Anti-Cancer Agents In Participants With Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study To Evaluate ELU001 In Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer